Aurora Cannabis earns spot on TIME Best Companies

Aurora Cannabis Inc. filed a Form 6-K highlighting that it has been named to TIME Canada's Best Companies 2026 list, becoming the first and only cannabis company ever to receive this recognition.

Rhea-AI Filing Summary

Aurora Cannabis Inc. filed a Form 6-K highlighting that it has been named to TIME Canada's Best Companies 2026 list, becoming the first and only cannabis company ever to receive this recognition. The ranking, developed with Statista, evaluates Canadian companies with at least US$100 million in 2024 or 2025 revenue and positive revenue growth over three years.

Only 125 companies qualified, based on employee satisfaction, revenue growth and sustainability transparency. Aurora links the award to its people-first culture, leadership programs, wellness initiatives and its focus on advancing the global medical cannabis industry across Canada, Europe, Australia and New Zealand.

Key Figures

Revenue threshold for ranking: US$100 million Companies on final list: 125 companies Recognition year: 2026

3 metrics

Revenue threshold for ranking US$100 million Minimum 2024 or 2025 revenue to qualify for TIME Canada's Best Companies 2026

Companies on final list 125 companies Total firms named to TIME Canada's Best Companies 2026

Recognition year 2026 TIME Canada's Best Companies list year in which Aurora was included

Key Terms

forward-looking information, Annual Information Form, GMP-certified manufacturing facilities, global medical cannabis, +1 more

5 terms

forward-looking information regulatory

"This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law"

Forward-looking information are predictions, plans, estimates or expectations about a company’s future performance, results or events, such as sales forecasts, project timelines, or anticipated costs. It matters to investors because these statements guide expectations but rely on assumptions and uncertain factors—like a weather forecast for a business—so investors should treat them as informed guesses rather than guarantees and consider the risks and possible changes behind the numbers.

Annual Information Form regulatory

"other risks as set out under "Risk Factors" contained in the Annual Information Form dated June 10, 2026"

A company's annual information form is a comprehensive regulatory filing that lays out its business description, key assets, risks, legal matters and other background details shareholders need to understand the company’s operations. Think of it as a detailed owner’s manual or dossier that supplements financial statements, helping investors do deeper homework on how the business works and what could affect its future performance.

GMP-certified manufacturing facilities technical

"With world-class GMP-certified manufacturing facilities in Canada and Germany"

global medical cannabis financial

"the Canadian-based leading global medical cannabis company"

sustainability transparency financial

"The ranking was based on employee satisfaction, revenue growth and sustainability transparency"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aurora Cannabis (ACB) announce in this Form 6-K?

Aurora Cannabis announced it was named to TIME Canada's Best Companies 2026 list. The recognition highlights its performance, employee focus and sustainability transparency, and marks Aurora as the first and only cannabis company ever to earn this distinction in Canada.

Why is TIME Canada's Best Companies 2026 recognition important for Aurora Cannabis (ACB)?

The recognition signals strong performance and workplace quality at Aurora Cannabis. TIME and Statista consider revenue growth, employee satisfaction and sustainability transparency, so inclusion suggests Aurora meets rigorous standards compared with other large Canadian companies across multiple operational dimensions.

What criteria were used to select TIME Canada's Best Companies 2026, including Aurora Cannabis (ACB)?

Companies needed at least US$100 million in 2024 or 2025 revenue and positive revenue growth over three years. TIME and Statista then ranked firms on employee satisfaction, revenue growth and sustainability transparency, ultimately selecting only 125 companies for the final Canadian list.

How does Aurora Cannabis (ACB) describe the culture and practices behind this recognition?

Aurora highlights a people-first culture supported by leadership development, wellness initiatives and community engagement. It connects the award to employees’ expertise and commitment, and to the company’s broader purpose of Opening the World to Cannabis™ through global medical cannabis operations and high-quality GMP-certified production.

In which markets does Aurora Cannabis (ACB) operate its medical cannabis business?

Aurora operates as a global medical cannabis leader serving patients in Canada, Europe, Australia and New Zealand. It supports these markets with GMP-certified manufacturing facilities in Canada and Germany and a portfolio of established brands such as Aurora, MedReleaf and Whistler Medical Marijuana Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/09/2026 - 05:03 PM EDT Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File No. 001-38691

AURORA CANNABIS INC. (Translation of registrant's name into English)

2207 90B St. SW
Edmonton, Alberta T6X 1V8
Canada
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  ☐ Form 40-F  ☒

SUBMITTED HEREWITH

Exhibits		Description
99.1		News release dated July 09, 2026

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AURORA CANNABIS INC.

/s/ Miguel Martin

Miguel Martin
Chief Executive Officer

Date: July 09, 2026

Exhibit 99.1 

 

Aurora Named to TIME Canada's Best Companies 2026 List

NASDAQ | TSX: ACB

The Company makes history as the first and only cannabis company to ever receive this recognition

EDMONTON, AB, July 9, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, has been awarded on TIME Canada's Best Companies 2026 list. This win reflects the Company's differentiated performance and commitment to industry excellence. To view the full award list, visit TIME.com.

 
Aurora named to TIME Canada's Best Companies 2026 list.

This prestigious award is presented by TIME in collaboration with Statista, the world-leading statistics portal and industry ranking provider. Canada's Best Companies of 2026 were identified through a multi-step evaluation of Canadian companies with at least US$100 million in revenue (2024 or 2025) and positive revenue growth over three years, with both relative and absolute growth assessed. The ranking was based on employee satisfaction, revenue growth and sustainability transparency - with only 125 companies earning a place on the final list.

"This is a proud milestone for Aurora and a meaningful recognition of our leadership strength in Canada," says Miguel Martin, CEO & Executive Chairman of Aurora. "Above all, this recognition belongs to our people. Every day, our teams bring deep expertise, care and commitment to advancing medical cannabis globally, and being named to TIME's Canada's Best Companies 2026 list is a powerful signal of the progress we've made, the credibility we've earned, and the standard we continue to set."

Being recognized on this list reflects the strength of Aurora's people-first culture and the Company's continued investment in creating a workplace where employees are supported and empowered to contribute. Through unique leadership development programs, wellness initiatives and purposeful opportunities to give back to local communities, Aurora has built a culture grounded in its values and driven by its purpose of Opening the World to Cannabis^™.  As the first and only cannabis company ever to be named to TIME's Canada's Best Companies list, this recognition underscores Aurora's ongoing commitment to investing in its people and advancing the global medical cannabis industry.

About Aurora

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora^®, MedReleaf^®, Pedanios^®, IndiMed^™, San Raf^®, and Whistler Medical Marijuana Corporation^®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis^™.   

Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Information  

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's ongoing commitment to investing in its people and accelerating the advancement of the global medical cannabis industry.

Forward-looking information or statements contained in this news release have been developed based on the Company and its management's good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and affect the Company's business and operations in the future.  Forward-looking information and statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management at the date the statements are made including, among other things,  assumptions about: development costs remaining consistent with budgets; the ability to manage anticipated and unanticipated costs; access to favorable equity and debt capital markets; the ability to raise sufficient capital to advance the business of the Company; favorable operating and economic conditions; political and regulatory stability; obtaining and maintaining all required licenses and permits; receipt of governmental approvals and permits; sustained labour stability; stability in financial and capital goods markets; favorable production levels and costs from the Company's operations; the pricing of various cannabis products; the level of demand for cannabis products; the availability of third-party service providers and other inputs for the Company's operations; and the Company's ability to conduct operations in a safe, efficient, and effective manner.  The Company does not give any assurance that the assumptions on which forward-looking information or statements are based will prove to be correct, or that the Company's business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company's control. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer  sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete construction projects and facilities improvements, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion to revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, and other risks as set out under "Risk Factors" contained in the Annual Information Form dated June 10, 2026 (the "2026 AIF"). Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements. The Company cautions that the list of risks, uncertainties and other factors described in the 2026 AIF is not exhaustive and other factors could also adversely affect its results.  Although the Company believes that the expectations conveyed by the forward-looking statements are reasonable based on the information available to the Company on the date hereof, no assurance can be given as to future results, approvals or achievements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-named-to-time-canadas-best-companies-2026-list-302822073.html

SOURCE Aurora Cannabis Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2026/09/c3737.html

%CIK: 0001683541

For further information: For Media: Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors: ICR, Inc., aurora@icrinc.com

CO: Aurora Cannabis Inc.

CNW 16:05e 09-JUL-26

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-991 NEWS RELEASE DATED JULY 9, 2026 11.3 KB
• EX-991 GRAPHIC 20.5 KB